Mutations in the GCK gene lead to two different diseases of blood glucose regulation: maturity-onset diabetes of the young type 2 (MODY-2), and persistent hyperinsulinemic hypoglycemia of infancy (PHHI) [47,48,49]. Here, GCK is linked to maturity-onset diabetes of the young type 2.